BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 17040006)

  • 1. A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy.
    Weaver TE; Cuellar N
    Sleep; 2006 Sep; 29(9):1189-94. PubMed ID: 17040006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J; Houghton WC
    Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group
    J Clin Sleep Med; 2005 Oct; 1(4):391-7. PubMed ID: 17564408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb; 25(1):42-9. PubMed ID: 11833860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy.
    Sleep; 2003 Feb; 26(1):31-5. PubMed ID: 12627729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy.
    Mamelak M; Black J; Montplaisir J; Ristanovic R
    Sleep; 2004 Nov; 27(7):1327-34. PubMed ID: 15586785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.
    Büchele F; Hackius M; Schreglmann SR; Omlor W; Werth E; Maric A; Imbach LL; Hägele-Link S; Waldvogel D; Baumann CR
    JAMA Neurol; 2018 Jan; 75(1):114-118. PubMed ID: 29114733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J; Swick T; Bogan R; Lai C; Carter LP
    Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.
    Plazzi G; Ruoff C; Lecendreux M; Dauvilliers Y; Rosen CL; Black J; Parvataneni R; Guinta D; Wang YG; Mignot E
    Lancet Child Adolesc Health; 2018 Jul; 2(7):483-494. PubMed ID: 30169321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    J Clin Sleep Med; 2010 Dec; 6(6):596-602. PubMed ID: 21206549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate.
    Murali H; Kotagal S
    Sleep; 2006 Aug; 29(8):1025-9. PubMed ID: 16944670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Criteria for gauging response to sodium oxybate for narcolepsy.
    Steffen AD; Lai C; Weaver TE
    J Sleep Res; 2018 Aug; 27(4):e12628. PubMed ID: 29205601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy.
    Roth T; Dauvilliers Y; Guinta D; Alvarez-Horine S; Dynin E; Black J
    J Sleep Res; 2017 Aug; 26(4):407-414. PubMed ID: 27807903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EFNS guidelines on management of narcolepsy.
    Billiard M; Bassetti C; Dauvilliers Y; Dolenc-Groselj L; Lammers GJ; Mayer G; Pollmächer T; Reading P; Sonka K;
    Eur J Neurol; 2006 Oct; 13(10):1035-48. PubMed ID: 16987156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
    Mansukhani MP; Kotagal S
    Sleep Med; 2012 Jun; 13(6):606-10. PubMed ID: 22445591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy.
    Bogan RK; Roth T; Schwartz J; Miloslavsky M
    J Clin Sleep Med; 2015 Apr; 11(4):427-32. PubMed ID: 25580605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial.
    Dauvilliers Y; Roth T; Bogan R; Thorpy MJ; Morse AM; Roy A; Dubow J; Gudeman J
    Sleep; 2023 Nov; 46(11):. PubMed ID: 37246913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of sodium oxybate as a treatment option for narcolepsy.
    Abad VC
    Expert Opin Pharmacother; 2019 Jul; 20(10):1189-1199. PubMed ID: 31136215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.